HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

International Cancer Research Conference

March 24-26, 2025 | Singapore

March 24 -26, 2025 | Singapore
ICC 2022

Dan Kenner

Speaker at Cancer Conference 2022 - Dan Kenner
ImunoBran Luxembourg and France, France
Title : BIOBRAN MGN-3; Effect of reducing side effects of chemotherapy in breast cancer patients

Abstract:

The aim of study was to assess the effect of Biobran in reducing of chemotherapy induced side effects in terms
of tiredness, anorexia, vomiting and hair loss and quality of life in terms of weight loss. Setting: Radiotherapy Department, Nishtar Hospital Multan. Material and Methods: Fifty patients of breast cancer were enrolled randomly in two groups. Group-A patients were given 3 gram dose of Biobran MGN-3 per day one week before and one week after chemotherapy. Group-B patient were given chemotherapy alone. Total six cycles of chemotherapy were given. No multivitamin or food supplements were given during this study.
Chemotherapy induced side effects (tiredness, anorexia, and vomiting, hair loss) were assessed by questionnaire to the patients before start of each cycle. Weight was checked before each cycle to assess weight gain or loss. White blood cells were checked by complete blood count just before and one week after chemotherapy. Results: Between six months, 50 patients were enrolled in Radiotherapy Department, Nishtar Hospital Multan. There was a significant reduction in tiredness and anorexia in group-A patients. 20 (80%) patients of
group-A felt increase in their diet and no tiredness without any appetizer or multivitamin. But group-B patients demanded for appetizer due to severe anorexia after chemotherapy except 3 (12%) patients who didn’t use any appetizer or food supplement. In group-A, 15 (60%) patients didn’t need any anti-emetic as compared to group-B all patient (100%) experienced severe nausea during and after chemotherapy. Group-A patients experienced less hair fall 7 (28%) patients as compared to other group which is 25 (100%) patients. Conclusions: The study showed that, by helping to optimize the immune system, Biobran MGN-3 can not only help maximize treatment
success, but also minimize treatment side effects and improve quality of life during treatment and in recovery.

Biography:

DAN KENNER, Ph.D., L.Ac graduated in 1979 from the Meiji College of Oriental Medicine in Japan, passed the Japanese National Licensing Examination and then trained in Internships at Osaka Medical University
Pain Clinic and Kinki University Medical Teaching Hospital. He is licensed to practice Oriental Medicine both in the U.S. and in Japan. He also has a Ph.D. in Naturopathic Medical Science from the First National University of Naturopathic Medical Sciences. Dr. Kenner is on the Board of Directors of the Acupuncture and Integrative Medicine College in Berkeley, California and the National Health Federation. He is author of The Whole-Body Workbook for Cancer and other titles. Since 1983, he has endeavoured to integrate the Naturopathic Medical Traditions of North America and Europe with the Traditional Medicine of East Asia.

Watsapp